Publications (188) MIGUEL ÁNGEL ARRABAL POLO publications

filter_list

2025

  1. Adjuvant treatment in intermediate/high-risk clear cell renal cell carcinoma. Systematic review

    Actas Urologicas Espanolas, Vol. 49, Núm. 2

  2. Long-Term Outcomes of Intravesical Mitomycin C Administered via Electromotive Drug Administration or Conductive Chemo-Hyperthermia in Non-Muscle-Invasive Bladder Cancer

    Cancers, Vol. 17, Núm. 3

2024

  1. Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review

    Urologic Oncology: Seminars and Original Investigations, Vol. 42, Núm. 9, pp. 251-265

  2. Initial results of pulsed thulium fiber laser (Dornier®) for the treatment of renal and ureteral stones with ureteroscopy

    Actas Urologicas Espanolas, Vol. 48, Núm. 6, pp. 484-485

  3. Paravesical aggressive angiomyxoma, a rare cause of pelvic tumor in men

    International Urology and Nephrology

2023

  1. A systematic review of the efficacy of intravesical electromotive drug administration therapy for non-muscle invasive bladder cancer

    Urologic Oncology: Seminars and Original Investigations, Vol. 41, Núm. 4, pp. 166-176

  2. Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 10, pp. 7453-7459

  3. Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer

    Urologic Oncology: Seminars and Original Investigations, Vol. 41, Núm. 2, pp. 109.e1-109.e8

  4. Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer

    Bladder Cancer, Vol. 9, Núm. 2, pp. 159-166

  5. Prostate health index (PHI) as an accurate prostate cancer predictor

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 11, pp. 9329-9335

  6. Results of fusion prostate biopsy comparing with cognitive and systematic biopsy

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 16, pp. 15085-15090

2022

  1. Applications of Platelet Rich Plasma in Urology

    Archivos Espanoles de Urologia, Vol. 75, Núm. 8, pp. 669-683

  2. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients

    Prostate Cancer and Prostatic Diseases, Vol. 25, Núm. 3, pp. 411-421

  3. Patients with periodontitis and erectile dysfunction suffer a greater incidence of major adverse cardiovascular events: A prospective study in a Spanish population

    Journal of Periodontology, Vol. 93, Núm. 8, pp. 1233-1242

2021

  1. Epidemiología de la utiasis urinaria en el mundo y en España

    Archivos Espanoles de Urologia, Vol. 74, Núm. 1, pp. 4-14

  2. Epididimitis tuberculosa

    Archivos espanoles de urologia, Vol. 74, Núm. 3, pp. 365-366

  3. EvaluaciÓn del tratamiento de litiasis renal radiopaca mediante la combinaciÓn de litotricia extracorpÓrea por ondas de choque y fagolitos plus®. Estudio preliminar de casos y controles

    Archivos Espanoles de Urologia, Vol. 74, Núm. 5, pp. 489-493

  4. Pneumorachis and spondylodiscitis caused by emphysematous pyelonephritis

    International Urology and Nephrology

  5. Ureterorrenoscopias en régimen ambulatorio. Adaptación del protocolo por la pandemia Covid-19

    Archivos espanoles de urologia, Vol. 74, Núm. 9, pp. 851-857

2020

  1. Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: A multicenter, placebo controlled, double blind, randomized clinical trial

    BMC Urology, Vol. 20, Núm. 1